{"id":"tears-naturale","safety":{"commonSideEffects":[{"rate":null,"effect":"Transient blurred vision"},{"rate":null,"effect":"Eye irritation"},{"rate":null,"effect":"Allergic reaction (rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This over-the-counter ophthalmic product contains a combination of lubricating agents and demulcents that mimic natural tear composition. It provides temporary relief of dry eye discomfort by coating the cornea and conjunctiva, reducing friction and maintaining moisture on the eye surface.","oneSentence":"Tears Naturale is an artificial tear solution that lubricates and moisturizes the ocular surface to relieve dry eye symptoms.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:11:28.388Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome / Keratoconjunctivitis sicca"},{"name":"Temporary relief of dry eye discomfort and irritation"}]},"trialDetails":[{"nctId":"NCT00758342","phase":"PHASE4","title":"Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)","status":"TERMINATED","sponsor":"Alcon Research","startDate":"2006-05","conditions":"Intraocular Pressure","enrollment":37},{"nctId":"NCT05314621","phase":"PHASE4","title":"A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Andover Research Eye Institute","startDate":"2021-12-31","conditions":"Allergic Conjunctivitis","enrollment":61},{"nctId":"NCT05265910","phase":"PHASE4","title":"A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Andover Research Eye Institute","startDate":"2021-12-14","conditions":"Allergic Conjunctivitis","enrollment":58},{"nctId":"NCT04970329","phase":"NA","title":"Corneal Thickness Changes in Patient Undergoing Dry Eye Managment","status":"UNKNOWN","sponsor":"University of Faisalabad","startDate":"2021-07","conditions":"Dry Eye Disease","enrollment":96},{"nctId":"NCT02308501","phase":"PHASE4","title":"A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2014-12","conditions":"Allergic Conjunctivitis","enrollment":25},{"nctId":"NCT00689078","phase":"PHASE4","title":"Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2008-05","conditions":"Allergic Conjunctivitis","enrollment":36},{"nctId":"NCT03192826","phase":"PHASE4","title":"Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy","status":"COMPLETED","sponsor":"University Hospital of Patras","startDate":"2016-06-20","conditions":"Posterior Capsule Opacification, Ocular Hypertension","enrollment":79},{"nctId":"NCT01730872","phase":"PHASE4","title":"Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2012-11","conditions":"Chronic Allergic Conjunctivitis","enrollment":16},{"nctId":"NCT01534195","phase":"PHASE4","title":"Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2012-01","conditions":"Allergic Conjunctivitis","enrollment":11},{"nctId":"NCT03406689","phase":"NA","title":"Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections","status":"COMPLETED","sponsor":"University Hospital of Patras","startDate":"2017-09-01","conditions":"Pain","enrollment":99},{"nctId":"NCT03211351","phase":"NA","title":"Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome","status":"COMPLETED","sponsor":"Huaxia Eye Hospital Group","startDate":"2017-07-01","conditions":"Dry Eye, Tear Film, Lipid Layer","enrollment":95},{"nctId":"NCT03434106","phase":"NA","title":"Sjögren's Syndrome Is Associated With Meibomian Gland Dysfunction","status":"UNKNOWN","sponsor":"LanZhou University","startDate":"2018-02-10","conditions":"Meibomian Gland Dysfunction, Sjögren's Syndrome","enrollment":60},{"nctId":"NCT01495338","phase":"PHASE1","title":"A Comparison of the Safety and Comfort of AC-170","status":"COMPLETED","sponsor":"Aciex Therapeutics, Inc.","startDate":"2011-12","conditions":"Normal Ocular Health","enrollment":60},{"nctId":"NCT03060005","phase":"NA","title":"Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?","status":"UNKNOWN","sponsor":"Tung Wah Hospital","startDate":"2017-05-01","conditions":"Sjögren's Syndrome, Meibomian Gland Dysfunction","enrollment":80},{"nctId":"NCT02821390","phase":"NA","title":"Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections","status":"COMPLETED","sponsor":"University Hospital of Patras","startDate":"2016-06","conditions":"Pain","enrollment":55},{"nctId":"NCT02837770","phase":"NA","title":"Effect of Topical and Oral Diclofenac on Pain Related to Intravitreal Injections","status":"COMPLETED","sponsor":"University Hospital of Patras","startDate":"2016-07","conditions":"Pain","enrollment":76},{"nctId":"NCT02992392","phase":"NA","title":"Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2016-12","conditions":"Dry Eye","enrollment":50},{"nctId":"NCT02817191","phase":"NA","title":"Effects of Holy-Comod and Tears Naturale Forte in Patients After Phaco+IOL","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2016-06","conditions":"Age-related Cataract","enrollment":80},{"nctId":"NCT02752763","phase":"PHASE4","title":"Comparison of Autologous Serum Versus Preservative Free Artificial Tear","status":"COMPLETED","sponsor":"Niğde State Hospital","startDate":"2015-10","conditions":"Dry Eye","enrollment":24},{"nctId":"NCT01119287","phase":"PHASE4","title":"Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-03","conditions":"Allergic Conjunctivitis","enrollment":180},{"nctId":"NCT01732757","phase":"PHASE4","title":"A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Allergan","startDate":"2012-11","conditions":"Conjunctivitis, Allergic","enrollment":157},{"nctId":"NCT01470118","phase":"PHASE4","title":"A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Allergan","startDate":"2011-10","conditions":"Conjunctivitis, Allergic","enrollment":127},{"nctId":"NCT01282138","phase":"PHASE4","title":"Assessment of Alcon's Ocular Image Quantification System","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-12","conditions":"Allergic Conjunctivitis","enrollment":13}],"_emaApprovals":[],"_faersSignals":[{"count":91,"reaction":"DRUG INEFFECTIVE"},{"count":67,"reaction":"EYE IRRITATION"},{"count":49,"reaction":"EYE PAIN"},{"count":40,"reaction":"OCULAR HYPERAEMIA"},{"count":34,"reaction":"DRY EYE"},{"count":34,"reaction":"VISION BLURRED"},{"count":32,"reaction":"EYE PRURITUS"},{"count":18,"reaction":"PAIN"},{"count":17,"reaction":"ASTHENOPIA"},{"count":17,"reaction":"FOREIGN BODY SENSATION IN EYES"}],"_approvalHistory":[],"publicationCount":18,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tears Naturale® II"],"phase":"marketed","status":"active","brandName":"Tears Naturale","genericName":"Tears Naturale","companyName":"Andover Research Eye Institute","companyId":"andover-research-eye-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tears Naturale is an artificial tear solution that lubricates and moisturizes the ocular surface to relieve dry eye symptoms. Used for Dry eye syndrome / Keratoconjunctivitis sicca, Temporary relief of dry eye discomfort and irritation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}